UK markets closed

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
85.94+1.26 (+1.49%)
At close: 04:00PM EDT
85.90 -0.04 (-0.05%)
After hours: 07:49PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in EUR. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
2,729,600
3,819,000
17,310,600
18,976,700
482,300
-
Cost of revenue
562,900
599,800
2,995,000
2,911,500
59,300
-
Gross profit
2,166,700
3,219,200
14,315,600
16,065,200
423,000
-
Operating expenses
Research development
1,956,600
1,783,100
1,537,000
949,200
645,000
-
Selling general and administrative
566,300
557,700
541,200
327,200
108,500
-
Total operating expenses
2,424,100
2,315,000
2,011,800
1,138,100
505,400
-
Operating income or loss
-257,400
904,200
12,303,800
14,927,100
-82,400
-
Interest expense
-
-
16,200
5,400
2,000
1,700
Total other income/expenses net
-
-67,800
620,700
145,100
-59,900
-
Income before tax
146,600
1,186,100
12,954,100
15,046,400
-145,800
-
Income tax expense
33,600
255,800
3,519,700
4,753,900
-161,000
-
Income from continuing operations
113,000
930,300
9,434,400
10,292,500
15,200
-
Net income
113,000
930,300
9,434,400
10,292,500
15,200
-
Net income available to common shareholders
113,000
930,300
9,434,400
10,292,500
15,200
-
Basic EPS
11.27
3.87
38.78
42.18
0.06
-
Diluted EPS
11.27
3.83
37.77
39.63
0.06
-
Basic average shares
241,956
240,600
243,300
244,000
253,300
-
Diluted average shares
241,956
242,700
249,800
259,700
253,300
-